Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 5/2007

01-10-2007 | ORIGINAL ARTICLE

Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians

Authors: Tomokazu Aoki, Ryo Nishikawa, Tomohiko Mizutani, Kuniharu Nojima, Kazuhiko Mishima, Jyunichi Adachi, Masao Matsutani

Published in: International Journal of Clinical Oncology | Issue 5/2007

Login to get access
Metadata
Title
Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians
Authors
Tomokazu Aoki
Ryo Nishikawa
Tomohiko Mizutani
Kuniharu Nojima
Kazuhiko Mishima
Jyunichi Adachi
Masao Matsutani
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 5/2007
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0687-5

Other articles of this Issue 5/2007

International Journal of Clinical Oncology 5/2007 Go to the issue

ORIGINAL ARTICLE

Pregnancy-related complications after vaginal radical trachelectomy for early-stage invasive uterine cervical cancer

REVIEW ARTICLE

The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias

CASE REPORT

Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma

CASE REPORT

Incidentally discovered adrenal myelolipoma associated with hyperthyroidism

REVIEW ARTICLE

PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia

ORIGINAL ARTICLE

Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits